Leica Biosystems Acquires Cell Idx, Moving Its Multiplexing Menu Forward With Ready-To-Use, Pre-Kitted Formulations
Nov 08, 2022•about 3 years ago
Acquiring Company
Leica Biosystems
Acquired Company
CELL IDX, INC
BostonSan DiegoNatural Language ProcessingMachine LearningArtificial IntelligenceDescription
Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging, has acquired Cell IDx, Inc., a leader in multiplexed tissue profiling. Founded in 2012 and headquartered in San Diego, California, Cell IDx provides multiplex staining panels, tissue staining, and imaging and analysis services.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed